FindTrial
Sign In

amphotericin B deoxycholate

DRUG9 trials

Sponsors

Aronex Pharmaceuticals, European Organisation for Research and Treatment of Cancer - EORTC, Banaras Hindu University, Drugs for Neglected Diseases, Astellas Pharma Global Development, Inc.

Conditions

AspergillomaCPACandidiasisCandidiasis, InvasiveChronic Myeloproliferative DisordersChronic Pulmonary AspergillosisInfectionLeishmaniasis, Visceral

Phase 2

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
TerminatedNCT01945281
Merck Sharp & Dohme LLCCandidiasis, Invasive
Start: 2014-01-15End: 2018-02-28Updated: 2019-11-25

Phase 3

Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
CompletedNCT00003031
European Organisation for Research and Treatment of Cancer - EORTCInfection, Pulmonary Complications
Start: 1997-06-30Target: 212Updated: 2012-07-02
Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer
CompletedNCT00002742
Aronex PharmaceuticalsChronic Myeloproliferative Disorders, Infection, Leukemia +3
Start: 1996-01-31End: 2007-09-30Updated: 2013-03-26
Combination Therapy in Indian Visceral Leishmaniasis
CompletedNCT00523965
Banaras Hindu UniversityLeishmaniasis, Visceral
Start: 2007-09-30End: 2010-02-28Target: 624Updated: 2010-05-26
Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis
CompletedNCT00628719
Banaras Hindu UniversityVisceral Leishmaniasis
Start: 2008-02-29End: 2009-03-31Target: 400Updated: 2009-04-03
Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis
CompletedNCT00696969
Drugs for Neglected DiseasesVisceral Leishmaniasis
Start: 2008-06-30End: 2010-01-31Updated: 2010-02-11
Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis
TerminatedNCT00815516
Astellas Pharma Global Development, Inc.Candidiasis
Start: 2013-02-28End: 2014-12-31Updated: 2015-11-04
A Trial to Compare Nebulized Amphotericin B and Nebulized Normal Saline as Maintenance in Patients With Chronic Pulmonary Aspergillosis
RecruitingNCT06447402
Post Graduate Institute of Medical Education and Research, ChandigarhAspergilloma, Chronic Pulmonary Aspergillosis, CPA
Start: 2024-06-03End: 2026-08-31Target: 196Updated: 2024-06-10

Phase 4

Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil
TerminatedNCT01310738
University of BrasiliaVisceral Leishmaniasis
Start: 2011-02-28End: 2015-02-28Updated: 2017-09-05

Related Papers

A randomized, double-blind trial investigating the efficacy of caspofungin versus amphotericin B deoxycholate in the treatment of invasive candidiasis in neonates and infants younger than 3 months of age
Journal of Antimicrobial Chemotherapy2019-10-0123 citations
1955. A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin vs. Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants ≤3 Months of Age
Open Forum Infectious Diseases2018-11-01
A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis.
2018-10-0125 citations
Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: A multicenter, randomized, open label trial
PLoS neglected tropical diseases2017-06-2971 citations
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.
2011-01-20218 citations
Single-dose liposomal amphotericin B for visceral leishmaniasis in India.
2010-02-01281 citations